Editorial: Facing the Upcoming of Multidrug-Resistant and Extensively Drug-Resistant Bacteria: Novel Antimicrobial Therapies (NATs)

Angel León-Buitimea; Jose Ruben Morones-Ramírez; Jason H Yang; Rafael Peña-Miller

doi:10.3389/fbioe.2021.636278

Editorial: Facing the Upcoming of Multidrug-Resistant and Extensively Drug-Resistant Bacteria: Novel Antimicrobial Therapies (NATs)

Front Bioeng Biotechnol. 2021 Feb 23:9:636278. doi: 10.3389/fbioe.2021.636278. eCollection 2021.

Authors

Angel León-Buitimea^{1

2}, Jose Ruben Morones-Ramírez^{1

2}, Jason H Yang^{3

4}, Rafael Peña-Miller⁵

Affiliations

¹ Facultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, UANL, San Nicolás de los Garza, Mexico.
² Centro de Investigación en Biotecnología y Nanotecnología, Facultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, Parque de Investigación e Innovación Tecnológica, Apodaca, Mexico.
³ Center for Emerging and Re-Emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ, United States.
⁴ Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ, United States.
⁵ Center for Genomic Sciences, Universidad Nacional Autónoma de México, Cuernavaca, Mexico.

No abstract available

Keywords: antibiotic resistance; antimicrobial peptides; antimicrobial therapies; combinatorial treatments; extensively drug-resistant bacteria; metal nanoparticles; multidrug-resistant bacteria.

Publication types

Editorial

Grants and funding

R00 GM118907/GM/NIGMS NIH HHS/United States